Variant report

Variant	esv2422201
Chromosome Location	chr11:107479362-107555825
allele	n/a
Outlinks	Ensembl UCSC

Chromatin state
Related regulatory elements
Target genes
Other information

No.	Transcrition factor	Chromosome Location	Cell Line	Cell type	Cell Stage	Matched TF binding sites
1	ATF1	chr11:107537932-107538032	K562	blood:	n/a	n/a
2	BATF	chr11:107549940-107550234	GM12878	blood:	n/a	chr11:107550057-107550068
3	BATF	chr11:107549940-107550117	GM12878	blood:	n/a	chr11:107550057-107550068
4	BCL11A	chr11:107549860-107550416	GM12878	blood:	n/a	chr11:107550355-107550364
5	BHLHE40	chr11:107542618-107542879	K562	blood:	n/a	n/a
6	BRCA1	chr11:107487918-107488014	Hela-S3	cervix:	n/a	n/a
7	CBX3	chr11:107522375-107522732	HCT-116	colon:	n/a	n/a
8	CEBPB	chr11:107495427-107495616	H1-hESC	embryonic stem cell:	n/a	chr11:107495501-107495512
9	CEBPB	chr11:107522057-107522063	K562	blood:	n/a	n/a
10	CEBPB	chr11:107498773-107498861	HepG2	liver:	n/a	chr11:107498802-107498813 chr11:107498800-107498813 chr11:107498800-107498811 chr11:107498800-107498813
11	CEBPB	chr11:107498752-107498856	H1-hESC	embryonic stem cell:	n/a	chr11:107498802-107498813 chr11:107498800-107498813 chr11:107498800-107498811 chr11:107498800-107498813
12	CEBPB	chr11:107527338-107527485	K562	blood:	n/a	chr11:107527401-107527414 chr11:107527403-107527414
13	CEBPB	chr11:107495424-107495579	HepG2	liver:	n/a	chr11:107495501-107495512
14	CEBPB	chr11:107495458-107495625	K562	blood:	n/a	chr11:107495501-107495512
15	CEBPB	chr11:107498700-107498900	K562	blood:	n/a	chr11:107498802-107498813 chr11:107498800-107498813 chr11:107498800-107498811 chr11:107498800-107498813
16	CEBPB	chr11:107548781-107548947	HepG2	liver:	n/a	chr11:107548864-107548875
17	CEBPB	chr11:107523899-107524111	H1-hESC	embryonic stem cell:	n/a	n/a
18	CEBPB	chr11:107480617-107480956	HepG2	liver:	n/a	n/a
19	CEBPB	chr11:107498665-107498928	IMR90	lung:	n/a	chr11:107498802-107498813 chr11:107498800-107498813 chr11:107498800-107498811 chr11:107498800-107498813
20	CEBPD	chr11:107517461-107517916	K562	blood:	n/a	n/a
21	CHD2	chr11:107549866-107550355	GM12878	blood:	n/a	n/a
22	CHD2	chr11:107480244-107480343	H1-hESC	embryonic stem cell:	n/a	n/a
23	CTCF	chr11:107480380-107480530	HCM	heart:	n/a	n/a
24	CTCF	chr11:107554600-107554750	AG09309	skin:	n/a	chr11:107554651-107554664
25	CTCF	chr11:107554580-107554730	GM12867	blood:	n/a	chr11:107554651-107554664
26	CTCF	chr11:107554640-107554790	HRE	kidney:	n/a	chr11:107554651-107554664
27	CTCF	chr11:107554520-107554670	HAc	cerebellar:	n/a	chr11:107554651-107554664
28	CTCF	chr11:107554640-107554790	HepG2	liver:	n/a	chr11:107554651-107554664
29	CTCF	chr11:107554620-107554770	AG04449	skin:	n/a	chr11:107554651-107554664
30	CTCF	chr11:107554580-107554730	HAc	cerebellar:	n/a	chr11:107554651-107554664
31	CTCF	chr11:107505480-107505630	HFF	foreskin:	n/a	n/a
32	CTCF	chr11:107554600-107554750	AG04450	lung:	n/a	chr11:107554651-107554664
33	CTCF	chr11:107554600-107554750	BJ	skin:	n/a	chr11:107554651-107554664
34	CTCF	chr11:107554600-107554750	SK-N-SH_RA	brain:	n/a	chr11:107554651-107554664
35	CTCF	chr11:107542700-107542709	GM12878	blood:	n/a	n/a
36	CTCF	chr11:107522500-107522650	HRE	kidney:	n/a	n/a
37	CTCF	chr11:107522540-107522690	HRPEpiC	eye:	n/a	n/a
38	CTCF	chr11:107554506-107554863	K562	blood:	n/a	chr11:107554651-107554664
39	CTCF	chr11:107542620-107542770	HCFaa	heart:	n/a	n/a
40	CTCF	chr11:107522500-107522650	NHDF-neo	bronchial:	n/a	n/a
41	CTCF	chr11:107505820-107505970	HCT-116	colon:	n/a	chr11:107505917-107505926
42	CTCF	chr11:107554620-107554770	GM12872	blood:	n/a	chr11:107554651-107554664
43	CTCF	chr11:107522460-107522610	HEK293	kidney:	n/a	n/a
44	CTCF	chr11:107554640-107554790	AG04450	lung:	n/a	chr11:107554651-107554664
45	CTCF	chr11:107522480-107522630	HCPEpiC	choroid plexus:	n/a	n/a
46	CTCF	chr11:107554360-107554510	HEK293	kidney:	n/a	n/a
47	CTCF	chr11:107554580-107554730	GM12864	blood:	n/a	chr11:107554651-107554664
48	CTCF	chr11:107554700-107554850	A549	lung:	n/a	n/a
49	CTCF	chr11:107554580-107554730	AG04449	skin:	n/a	chr11:107554651-107554664
50	CTCF	chr11:107554580-107554730	RPTEC	kidney:	n/a	chr11:107554651-107554664

No.	Chromosome Location	Cell Line	Cell type	Cell Stage
1	chr11:107540995-107541045	HUVEC	blood vessel:	n/a
2	chr11:107496475-107496525	HPAEpiC	pulmonary alveolar:	n/a
3	chr11:107496475-107496525	NH-A	brain:	n/a
4	chr11:107540995-107541045	HEK293	kidney:	embryo
5	chr11:107537213-107537263	SKMC	muscle:	n/a
6	chr11:107496475-107496525	HCT-116	colon:	n/a
7	chr11:107540995-107541045	Caco-2	colon:	n/a
8	chr11:107540995-107541045	HPAEpiC	pulmonary alveolar:	n/a
9	chr11:107496475-107496525	IMR90	lung:	fetal
10	chr11:107519203-107519253	K562	blood:	n/a
11	chr11:107519203-107519253	SK-N-SH_RA	brain:	n/a
12	chr11:107540995-107541045	HepG2	liver:	n/a
13	chr11:107540995-107541045	HRPEpiC	eye:	n/a
14	chr11:107496475-107496525	PANC-1	pancreas:	n/a
15	chr11:107519203-107519253	SAEC	small airway:	n/a
16	chr11:107537213-107537263	BJ	skin:	n/a
17	chr11:107519203-107519253	HEEpiC	esophagus:	n/a
18	chr11:107540995-107541045	ProgFib	skin:	n/a
19	chr11:107496475-107496525	BJ	skin:	n/a
20	chr11:107540995-107541045	AG04449	skin:	fetal
21	chr11:107537213-107537263	HRE	kidney:	n/a
22	chr11:107537213-107537263	HCT-116	colon:	n/a
23	chr11:107496475-107496525	HepG2	liver:	n/a
24	chr11:107496475-107496525	MCF-7	breast:	n/a
25	chr11:107496475-107496525	HL-60	blood:	n/a
26	chr11:107496475-107496525	ovcar-3	ovarian:	n/a
27	chr11:107496475-107496525	MCF10A-Er-Src	breast:	n/a
28	chr11:107496475-107496525	SK-N-MC	brain:	n/a
29	chr11:107540995-107541045	HCF	heart:	n/a
30	chr11:107496475-107496525	AG10803	skin:	n/a
31	chr11:107537213-107537263	HRCEpiC	kidney:	n/a
32	chr11:107496475-107496525	HIPEpiC	eye:	n/a
33	chr11:107519203-107519253	HRCEpiC	kidney:	n/a
34	chr11:107537213-107537263	MCF-7	breast:	n/a
35	chr11:107537213-107537263	PANC-1	pancreas:	n/a
36	chr11:107519203-107519253	HAEpiC	amniotic membrane:	n/a
37	chr11:107537213-107537263	NH-A	brain:	n/a
38	chr11:107540995-107541045	CMK	blood:	n/a
39	chr11:107519203-107519253	HEK293	kidney:	embryo
40	chr11:107496475-107496525	SKMC	muscle:	n/a
41	chr11:107496475-107496525	HRCEpiC	kidney:	n/a
42	chr11:107537213-107537263	SAEC	small airway:	n/a
43	chr11:107540995-107541045	Hepatocyte	liver:	n/a
44	chr11:107537213-107537263	HAEpiC	amniotic membrane:	n/a
45	chr11:107496475-107496525	GM12891	blood:	n/a
46	chr11:107540995-107541045	HCT-116	colon:	n/a
47	chr11:107519203-107519253	GM06990	blood:	n/a
48	chr11:107540995-107541045	GM12878	blood:	n/a
49	chr11:107537213-107537263	SK-N-SH_RA	brain:	n/a
50	chr11:107496475-107496525	CMK	blood:	n/a

No.	Distal block	Cell Line	Cell type
1	chr11:107533663..107536332-chr11:107539088..107541417,2	K562	blood:
2	chr11:107492917..107496514-chr11:107496948..107499847,3	K562	blood:
3	chr11:107518067..107520406-chr11:107522750..107524559,2	K562	blood:
4	chr11:107533663..107536332-chr11:107539088..107541417,2	K562	blood:
5	chr11:107499538..107501621-chr11:107504588..107506113,2	K562	blood:
6	chr11:107545277..107546932-chr11:107553541..107555478,2	K562	blood:
7	chr11:107499538..107501877-chr11:107503729..107506113,2	K562	blood:
8	chr11:107473623..107475571-chr11:107491521..107493538,2	MCF-7	breast:
9	chr11:107499538..107501621-chr11:107504588..107506113,2	K562	blood:
10	chr11:107499538..107501877-chr11:107503729..107506113,2	K562	blood:
11	chr11:107553206..107555890-chr11:107557656..107559672,2	K562	blood:
12	chr11:107545277..107546932-chr11:107553541..107555478,2	K562	blood:
13	chr11:107492917..107496514-chr11:107496948..107499847,3	K562	blood:

No.	lncRNA name	Chromosome Location	lncRNA alias
1	lnc-AP001024.2-2	chr11:107490762-107491196	NONHSAT023998
2	lnc-SLN-1	chr11:107513613-107513761	NONHSAT024000
3	lnc-AP001024.2-2	chr11:107488831-107488932	NONHSAT023998
4	lnc-AP001024.2-2	chr11:107494005-107494590	NONHSAT023996
5	lnc-AP001024.2-2	chr11:107488831-107488932	NONHSAT023996
6	lnc-SLN-1	chr11:107514087-107514597	NONHSAT024000

Variant related genes	Relation type
ENSG00000254758	TF binding region
ELMOD1	TF binding region
ENSG00000254758	CpG island
ELMOD1	CpG island
ENSG00000110675	chromatin interactions

Extended variants
information (count: 2704 )
Associated
traits (count: 96 )

Variant overlapped rSNPs/rCNVs (count:2704 , 50 per page) page: 1 2 3 4 5 6 7 ... 55

No.	Variant name	Chromosome position	Chromatin state	Related regulatory elements	Target genes	Extended variants	Associated traits
1	rs543447939	chr11:107479367-107479368	Enhancers Weak transcription Bivalent Enhancer	n/a	n/a	Overlapped CNVs	n/a
2	rs565403211	chr11:107479438-107479439	Enhancers Weak transcription Bivalent Enhancer	n/a	n/a	Overlapped CNVs	n/a
3	rs532451814	chr11:107479470-107479471	Enhancers Weak transcription Bivalent Enhancer	n/a	n/a	Overlapped CNVs	n/a
4	rs112651714	chr11:107479477-107479478	Enhancers Weak transcription Bivalent Enhancer	n/a	n/a	Overlapped CNVs	n/a
5	rs531097	chr11:107479478-107479479	Enhancers Weak transcription Bivalent Enhancer	n/a	n/a	LD-proxies of rSNP Overlapped rCNV	mRNA abundance
6	rs565629207	chr11:107479558-107479559	Enhancers Weak transcription Bivalent Enhancer	n/a	n/a	Overlapped CNVs	n/a
7	rs534660146	chr11:107479559-107479560	Enhancers Weak transcription Bivalent Enhancer	n/a	n/a	Overlapped CNVs	n/a
8	rs527435882	chr11:107479643-107479644	Enhancers Weak transcription Bivalent Enhancer Flanking Bivalent TSS/Enh	n/a	n/a	Overlapped CNVs	n/a
9	rs12281067	chr11:107479645-107479646	Enhancers Weak transcription Bivalent Enhancer Flanking Bivalent TSS/Enh	n/a	n/a	LD-proxies of rSNP Overlapped rCNV	n/a
10	rs532859	chr11:107479652-107479653	Enhancers Weak transcription Bivalent Enhancer Flanking Bivalent TSS/Enh	n/a	n/a	LD-proxies of rSNP Overlapped rCNV	mRNA abundance
11	rs142672432	chr11:107479672-107479673	Enhancers Weak transcription Bivalent Enhancer Flanking Bivalent TSS/Enh	n/a	n/a	Overlapped CNVs	n/a
12	rs117325594	chr11:107479790-107479791	Enhancers Weak transcription Bivalent Enhancer Flanking Bivalent TSS/Enh	n/a	n/a	Overlapped CNVs	n/a
13	rs571229433	chr11:107479911-107479912	Enhancers Weak transcription Bivalent Enhancer	n/a	n/a	Overlapped CNVs	n/a
14	rs538763426	chr11:107480021-107480022	Enhancers Weak transcription Bivalent Enhancer	n/a	n/a	Overlapped CNVs	n/a
15	rs181493737	chr11:107480036-107480037	Enhancers Weak transcription Bivalent Enhancer	n/a	n/a	Overlapped CNVs	n/a
16	rs555432529	chr11:107480100-107480101	Enhancers Weak transcription Bivalent Enhancer	n/a	n/a	Overlapped CNVs	n/a
17	rs369657863	chr11:107480104-107480105	Enhancers Weak transcription Bivalent Enhancer	n/a	n/a	Overlapped CNVs	n/a
18	rs566287293	chr11:107480134-107480135	Enhancers Weak transcription Bivalent Enhancer	n/a	n/a	Overlapped CNVs	n/a
19	rs151020362	chr11:107480161-107480162	Enhancers Weak transcription Bivalent Enhancer	n/a	n/a	Overlapped CNVs	n/a
20	rs555287509	chr11:107480190-107480191	Enhancers Weak transcription Bivalent Enhancer	n/a	n/a	Overlapped CNVs	n/a
21	rs186486126	chr11:107480191-107480192	Enhancers Weak transcription Bivalent Enhancer	n/a	n/a	Overlapped CNVs	n/a
22	rs557212312	chr11:107480197-107480198	Enhancers Weak transcription Bivalent Enhancer	n/a	n/a	Overlapped CNVs	n/a
23	rs34880725	chr11:107480246-107480247	Enhancers Weak transcription Bivalent Enhancer Flanking Active TSS	n/a	n/a	Overlapped CNVs	n/a
24	rs111452364	chr11:107480296-107480297	Enhancers Weak transcription Bivalent Enhancer Flanking Active TSS	n/a	n/a	Overlapped CNVs	n/a
25	rs558692845	chr11:107480363-107480364	Enhancers Weak transcription Bivalent Enhancer Flanking Active TSS	n/a	n/a	Overlapped CNVs	n/a
26	rs544376223	chr11:107480404-107480405	Enhancers Bivalent Enhancer Weak transcription Flanking Active TSS	n/a	n/a	Overlapped CNVs	n/a
27	rs576797830	chr11:107480425-107480426	Enhancers Bivalent Enhancer Weak transcription Flanking Active TSS	n/a	n/a	Overlapped CNVs	n/a
28	rs190187710	chr11:107480426-107480427	Enhancers Bivalent Enhancer Weak transcription Flanking Active TSS	n/a	n/a	Overlapped CNVs	n/a
29	rs181886773	chr11:107480444-107480445	Enhancers Bivalent Enhancer Weak transcription Flanking Active TSS	n/a	n/a	Overlapped CNVs	n/a
30	rs150502321	chr11:107480445-107480446	Enhancers Bivalent Enhancer Weak transcription Flanking Active TSS	n/a	n/a	Overlapped CNVs	n/a
31	rs187370534	chr11:107480500-107480501	Enhancers Bivalent Enhancer Weak transcription Flanking Active TSS	n/a	n/a	Overlapped CNVs	n/a
32	rs79438296	chr11:107480533-107480534	Enhancers Bivalent Enhancer Weak transcription Flanking Active TSS	n/a	n/a	Overlapped CNVs	n/a
33	rs117718922	chr11:107480550-107480551	Enhancers Bivalent Enhancer Weak transcription Flanking Active TSS	n/a	n/a	Overlapped CNVs	n/a
34	rs565427606	chr11:107480675-107480676	Enhancers Bivalent Enhancer Weak transcription	n/a	n/a	Overlapped CNVs	n/a
35	rs114140114	chr11:107480732-107480733	Enhancers Bivalent Enhancer Weak transcription	n/a	n/a	Overlapped CNVs	n/a
36	rs147787000	chr11:107480790-107480791	Enhancers Bivalent Enhancer Weak transcription	n/a	n/a	Overlapped CNVs	n/a
37	rs541063147	chr11:107480813-107480814	Enhancers Bivalent Enhancer Weak transcription	n/a	n/a	Overlapped CNVs	n/a
38	rs564879479	chr11:107480825-107480826	Enhancers Bivalent Enhancer Weak transcription	n/a	n/a	Overlapped CNVs	n/a
39	rs372243402	chr11:107480862-107480863	Enhancers Bivalent Enhancer Weak transcription	n/a	n/a	Overlapped CNVs	n/a
40	rs565690	chr11:107480925-107480926	Enhancers Bivalent Enhancer Weak transcription	n/a	n/a	Overlapped CNVs	n/a
41	rs578013322	chr11:107480942-107480943	Enhancers Bivalent Enhancer Weak transcription	n/a	n/a	Overlapped CNVs	n/a
42	rs34402114	chr11:107481038-107481039	Enhancers Weak transcription	n/a	n/a	Overlapped CNVs	n/a
43	rs601832	chr11:107481094-107481095	Enhancers Weak transcription	n/a	n/a	Overlapped CNVs	n/a
44	rs565775171	chr11:107481095-107481096	Enhancers Weak transcription	n/a	n/a	Overlapped CNVs	n/a
45	rs536876544	chr11:107481101-107481102	Enhancers Weak transcription	n/a	n/a	Overlapped CNVs	n/a
46	rs548475927	chr11:107481247-107481248	Weak transcription Enhancers	n/a	n/a	Overlapped CNVs	n/a
47	rs375509925	chr11:107481258-107481259	Weak transcription Enhancers	n/a	n/a	Overlapped CNVs	n/a
48	rs141245502	chr11:107481265-107481266	Weak transcription Enhancers	n/a	n/a	Overlapped CNVs	n/a
49	rs190895225	chr11:107481273-107481274	Weak transcription Enhancers	n/a	n/a	Overlapped CNVs	n/a
50	rs116990876	chr11:107481282-107481283	Weak transcription Enhancers	n/a	n/a	Overlapped CNVs	n/a

Variant related diseases (count:96)

Disease	PMID	Source
Medulloblastoma	21979893	CNVD
Gastric cancer	17908304	CNVD
Multiple myeloma	20724749	CNVD
Wilms tumour	21544195	CNVD
Chronic lymphocytic leukemia	21546498	CNVD
Intellectual disability	22102821	CNVD
Autism	22495311	CNVD
Acute myeloid leukemia	20729466	CNVD
Cancer	21637783	CNVD
Acute myeloid leukemia	16864856	CNVD
Chronic lymphocytic leukemia	21795749	CNVD
Esophageal squamous carcinoma	21637470	CNVD
Neuroblastoma	21484798	CNVD
Ewing''s sarcoma	21437220	CNVD
Oral cancer	21386901	CNVD
Endometrial cancer	22040021	CNVD
Breast cancer	20837533	CNVD
Breast cancer	21264507	CNVD
Cervical cancer	21063398	CNVD
Glioblastoma multiforme	19960244	CNVD
Liposarcoma	21253554	CNVD
Neuroblastoma	18923524	CNVD
Neuroblastoma	18664255	CNVD
Monoclonal gammopathy of undetermined significance	17077331	CNVD
Multiple myeloma	17077331	CNVD
Neuroblastoma	17533364	CNVD
Acute lymphoblastic leukemia	20435627	CNVD
Basal cell lymphoma	16317097	CNVD
Diffuse large b-cell lymphoma	16317097	CNVD
Glioblastoma multiforme	21080181	CNVD
Cancer	16751803	CNVD
Seminomas	18059402	CNVD
Cervical cancer	21062161	CNVD
Esophageal squamous carcinoma	18350619	CNVD
T-cell prolymphocytic leukemia	19278963	CNVD
lymphocytic leukemia	21291569	CNVD
Acute lymphoblastic leukemia	21339820	CNVD
Hodgkin''s lymphoma	17606441	CNVD
Neuroblastoma	18923191	CNVD
Acute lymphoblastic leukemia	20067559	CNVD
Cancer	22429812	CNVD
Breast cancer	16608533	CNVD
T-cell lymphomas	19863542	CNVD
Melanoma	18172304	CNVD
Acute lymphoblastic leukemia	17690704	CNVD
Basal cell lymphoma	17053054	CNVD
Hepatocellular carcinoma	16785998	CNVD
Acute lymphoblastic leukemia	22237106	CNVD
Acute myeloid leukemia	21251322	CNVD
Breast cancer	21858162	CNVD
Breast cancer	21785460	CNVD
Breast cancer	21958427	CNVD
Lung cancer	18438408	CNVD
Ewing''s sarcoma	17952124	CNVD
Breast cancer	17133270	CNVD
T-cell prolymphocytic leukemia	17713554	CNVD
Acute lymphoblastic leukemia	21098271	CNVD
small cell lung cancer	20016488	CNVD
Breast cancer	17603634	CNVD
T-cell acute lymphoblastic leukemia	18185524	CNVD
Basal cell lymphoma	16790693	CNVD
Chronic lymphocytic leukemia	21670202	CNVD
Breast cancer	21364760	CNVD
Ovarian clear cell carcinoma	19293255	CNVD
Mental retardation	19966786	CNVD
Non-small cell lung cancer	21829676	CNVD
Invasive pancreatic ductal carcinoma	16982739	CNVD
Intracranial aneurysm	16715129	CNVD
Ovine squamous-cell carcinoma	17599052	CNVD
Basal cell lymphoma	17170743	CNVD
Follicular lymphoma	17170743	CNVD
Urothelial carcinoma	21177765	CNVD
Myelofibrosis	22110671	CNVD
Ovarian cancer	21720365	CNVD
Chronic lymphocytic leukemia	17805327	CNVD
Glioblastoma multiforme	22286061	CNVD
Breast cancer	16397240	CNVD
Chronic lymphocytic leukemia	18922857	CNVD
Neuroblastoma	17327916	CNVD
Esophageal adenocarcinoma	18519675	CNVD
Esophageal squamous carcinoma	17470683	CNVD
Mantle cell lymphoma	19029149	CNVD
Malignant peripheral nerve sheath tumor	18522746	CNVD
Malignant melanoma	17260012	CNVD
Endometrioid adenocarcinoma	16974079	CNVD
Prostate cancer	16573809	CNVD
Prostate cancer	18632612	CNVD
Obesity	19966786	CNVD
Renal cell carcinoma	21668985	CNVD
Cancer	20164920	CNVD
Cancer	20164919	CNVD
Breast cancer	22522925	CNVD
Pancreatic cancer	17952125	CNVD
Acute lymphoblastic leukemia	18458336	CNVD
Non-syndromic sensorineural hearing loss	18451855	CNVD
Attention deficit hyperactivity disorder	19546859	CNVD

Chromatin state (count:341 , 50 per page) page: 1 2 3 4 5 6 7

No.	Chromosome Location	Chromatin state	Cell line	Tissue
1	chr11:107463200-107482600	Weak transcription	HSMMtube	muscle
2	chr11:107477200-107479400	Weak transcription	H9 Derived Neuron Cultured Cells	ES cell derived
3	chr11:107477200-107479600	Weak transcription	H1 Cell Line	embryonic stem cell
4	chr11:107477200-107480400	Weak transcription	H9 Cell Line	embryonic stem cell
5	chr11:107478400-107481000	Enhancers	hESC Derived CD56+ Ectoderm Cultured Cells	ES cell derived
6	chr11:107478600-107481000	Enhancers	HUVEC	blood vessel
7	chr11:107478800-107480400	Enhancers	HUES6 Cell Line	embryonic stem cell
8	chr11:107478800-107480400	Enhancers	iPS-20b Cell Line	embryonic stem cell
9	chr11:107479000-107480000	Enhancers	ES-UCSF4 Cell Line	embryonic stem cell
10	chr11:107479000-107480600	Enhancers	ES-I3 Cell Line	embryonic stem cell
11	chr11:107479000-107480600	Enhancers	iPS-15b Cell Line	embryonic stem cell
12	chr11:107479000-107481000	Enhancers	H9 Derived Neuronal Progenitor Cultured Cells	ES cell derived
13	chr11:107479200-107479600	Bivalent Enhancer	iPS-18 Cell Line	embryonic stem cell
14	chr11:107479200-107479800	Bivalent Enhancer	HUES48 Cell Line	embryonic stem cell
15	chr11:107479200-107481000	Bivalent Enhancer	HUES64 Cell Line	embryonic stem cell
16	chr11:107479400-107480200	Enhancers	Liver	Liver
17	chr11:107479400-107481200	Enhancers	H9 Derived Neuron Cultured Cells	ES cell derived
18	chr11:107479600-107479800	Enhancers	H1 Cell Line	embryonic stem cell
19	chr11:107479600-107479800	Flanking Bivalent TSS/Enh	iPS-18 Cell Line	embryonic stem cell
20	chr11:107479600-107480600	Enhancers	H1 BMP4 Derived Mesendoderm Cultured Cells	ES cell derived
21	chr11:107479800-107480600	Enhancers	HUES48 Cell Line	embryonic stem cell
22	chr11:107479800-107481000	Bivalent Enhancer	iPS-18 Cell Line	embryonic stem cell
23	chr11:107480000-107480600	Weak transcription	ES-UCSF4 Cell Line	embryonic stem cell
24	chr11:107480200-107480400	Bivalent Enhancer	Mesenchymal Stem Cell Derived Adipocyte Cultured Cells	ES cell derived
25	chr11:107480200-107480400	Bivalent Enhancer	Foreskin Melanocyte Primary Cells skin03	Skin
26	chr11:107480200-107480600	Flanking Active TSS	Liver	Liver
27	chr11:107480200-107481000	Enhancers	Adipose Nuclei	Adipose
28	chr11:107480400-107480600	Enhancers	H9 Cell Line	embryonic stem cell
29	chr11:107480400-107481000	Bivalent Enhancer	iPS-20b Cell Line	embryonic stem cell
30	chr11:107480400-107481400	Enhancers	Mesenchymal Stem Cell Derived Adipocyte Cultured Cells	ES cell derived
31	chr11:107480600-107480800	Enhancers	ES-UCSF4 Cell Line	embryonic stem cell
32	chr11:107480600-107481400	Enhancers	Liver	Liver
33	chr11:107481000-107483200	Weak transcription	HUVEC	blood vessel
34	chr11:107481200-107489000	Weak transcription	H9 Derived Neuron Cultured Cells	ES cell derived
35	chr11:107482600-107482800	Enhancers	HSMMtube	muscle
36	chr11:107483200-107483400	Enhancers	Liver	Liver
37	chr11:107483200-107484400	Enhancers	HUVEC	blood vessel
38	chr11:107483600-107483800	Enhancers	HUES64 Cell Line	embryonic stem cell
39	chr11:107484400-107489200	Weak transcription	HUVEC	blood vessel
40	chr11:107489000-107489200	ZNF genes & repeats	H9 Derived Neuron Cultured Cells	ES cell derived
41	chr11:107489200-107492400	Enhancers	HUVEC	blood vessel
42	chr11:107489200-107502200	Weak transcription	HSMM	muscle
43	chr11:107489200-107508800	Weak transcription	H9 Derived Neuron Cultured Cells	ES cell derived
44	chr11:107490600-107491000	Weak transcription	HSMMtube	muscle
45	chr11:107491000-107491200	Enhancers	HSMMtube	muscle
46	chr11:107491200-107491400	Enhancers	Brain Anterior Caudate	brain
47	chr11:107491200-107532000	Weak transcription	HSMMtube	muscle
48	chr11:107492400-107492800	Weak transcription	Brain Anterior Caudate	brain
49	chr11:107492400-107495200	Weak transcription	HUVEC	blood vessel
50	chr11:107493000-107494200	Enhancers	Brain Anterior Caudate	brain

The 2.0 version of rSNPBase

Variant report

Quick Search:

what's new

Quick links